US 12,268,229 B2
Liquid concentrate composition
Mary Elizabeth Quinlan, London (GB); Sven Tiedemann, Lübeck (DE); and Chun Jenny Siegfeld, Lübeck (DE)
Assigned to Tate & Lyle Solutions USA LLC, Hoffman Estates, IL (US)
Filed by Tate & Lyle Solutions USA LLC, Hoffman Estates, IL (US)
Filed on Dec. 17, 2021, as Appl. No. 17/554,998.
Application 17/554,998 is a continuation of application No. PCT/GB2020/051481, filed on Jun. 18, 2020.
Claims priority of application No. 1908813 (GB), filed on Jun. 19, 2019.
Prior Publication US 2022/0125085 A1, Apr. 28, 2022
Int. Cl. A23L 27/30 (2016.01); A23L 2/385 (2006.01); A23L 2/44 (2006.01); A23L 2/60 (2006.01); A23L 2/68 (2006.01)
CPC A23L 27/36 (2016.08) [A23L 2/385 (2013.01); A23L 2/44 (2013.01); A23L 2/60 (2013.01); A23L 2/68 (2013.01)] 19 Claims
OG exemplary drawing
 
1. A liquid concentrate composition comprising:
steviol glycosides, wherein the steviol glycosides include rebaudioside M in an amount of about 800 ppm or more by total weight of the liquid concentrate composition;
a stabiliser comprising xanthan and/or iota-carrageenan; and water;
wherein the pH of the liquid concentrate composition is less than about 7.